Cargando…
Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid
BACKGROUND: Weight gain is the most frequent adverse effect of valproic acid (VPA) treatment, resulting in poor compliance and many endocrine disturbances. Similarities in the weight change of monozygotic twins receiving VPA strongly suggests that genetic factors are involved in this effect. However...
Autores principales: | Li, Hongliang, Wang, Xueding, Zhou, Yafang, Ni, Guanzhong, Su, Qibiao, Chen, Ziyi, Chen, Zhuojia, Li, Jiali, Chen, Xinmeng, Hou, Xiangyu, Xie, Wen, Xin, Shuang, Zhou, Liemin, Huang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540110/ https://www.ncbi.nlm.nih.gov/pubmed/25740917 http://dx.doi.org/10.1093/ijnp/pyv021 |
Ejemplares similares
-
Effects of Antiepileptic Drug Monotherapy on One-Carbon Metabolism and DNA Methylation in Patients with Epilepsy
por: Ni, Guanzhong, et al.
Publicado: (2015) -
Increased homocysteine levels in valproate-treated patients with epilepsy: a meta-analysis
por: Ni, Guanzhong, et al.
Publicado: (2014) -
Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period
por: Ma, Jiuhong, et al.
Publicado: (2022) -
Anomalous expression of chloride transporters in the sclerosed hippocampus of mesial temporal lobe epilepsy patients
por: Cai, Xiaodong, et al.
Publicado: (2013) -
La Lepre
Publicado: (1934)